Developing a new enzyme platform for precise chemical reactions
An Evolvable Metalloenzyme Platform for Stereoselective Radical Biocatalysis
This study is working on a new way to help make medicines by using special proteins that can be trained to create specific chemical compounds more accurately, which could lead to better and more effective treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Barbara NIH-funded |
| Lab location | 1 site (Santa Barbara, United States) |
| Project ID | NIH-11061841 on NIH RePORTER |
What this research studies
This research focuses on creating a novel metalloenzyme platform that can control the stereochemistry of chemical reactions, which is crucial for producing specific compounds in pharmaceuticals and other industries. By combining techniques from various fields such as organic chemistry and enzyme engineering, the researchers aim to reprogram natural enzymes to perform new types of reactions with high precision. Patients may benefit from the development of more effective drugs and therapies that rely on these advanced chemical processes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals with conditions that could be treated by new pharmaceutical compounds developed through these advanced chemical processes.
Not a fit: Patients with conditions that do not require new drug development or those not affected by the types of compounds being synthesized may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective and targeted medications for various conditions.
How similar studies have performed: Other research has shown success in using engineered enzymes for specific chemical reactions, indicating that this approach has potential for significant advancements.
Where this research is happening
Santa Barbara, United States
- University of California Santa Barbara — Santa Barbara, United States (Active)
Researchers
- Principal investigator: Yang, Yang — University of California Santa Barbara
- Study coordinator: Yang, Yang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.